Discontinued ProductUnfortunately Butylscopolammonium bromide (Cat. No. 0418) has been withdrawn from sale for commercial reasons.
Muscarinic antagonist. Antispasmodic.
|Storage||Store at RT|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Preparing Stock Solutions
The following data is based on the product molecular weight 440.38. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||2.27 mL||11.35 mL||22.71 mL|
|5 mM||0.45 mL||2.27 mL||4.54 mL|
|10 mM||0.23 mL||1.14 mL||2.27 mL|
|50 mM||0.05 mL||0.23 mL||0.45 mL|
References are publications that support the products' biological activity.
Pfaffendorf et al (1991) Comparison of various spasmolytic drugs on guinea-pig isolated common bile duct. Naunyn Schmiedebergs Arch.Pharmacol. 344 114 PMID: 1775188
View Related Products by Product Action
Keywords: Butylscopolamine bromide, supplier, Butylscopolamine, Non-selective, Muscarinics, Non-selective, Muscarinics, Tocris Bioscience
Citations for Butylscopolammonium bromide
Citations are publications that use Tocris products.
Currently there are no citations for Butylscopolammonium bromide.
Reviews for Butylscopolammonium bromide
There are currently no reviews for this product. Be the first to review Butylscopolammonium bromide and earn rewards!
Have you used Butylscopolammonium bromide?
Submit a review and receive an Amazon gift card.
$10US/$10CAN/€7/£6 gift card for a review without an image
$25US/$25CAN/€18/£15 gift card for a review with an image
*Offer only valid in the USA / Canada, UK and EuropeSubmit a Review
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* or download your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Alzheimer's disease (AD) is a degenerative brain disease and the most common cause of dementia, affecting approximately 47 million people worldwide. Updated in 2015, this poster summarizes the structural and functional changes observed in the progression of this neurodegenerative disease, as well as classic AD drug targets.
Learning & Memory Poster
Recognition memory enables us to make judgements about whether or not we have encountered a particular stimulus before. This poster outlines the cellular mechanisms underlying recognition memory and its links to long-term depression, as well as the use of pharmacological intervention to assess the role of neurotransmitters in recognition memory.
Schizophrenia is a debilitating psychiatric disorder that affects 1% of the worldwide population. This poster describes the neurobiology of Schizophrenia, as well as highlighting the genetic and environmental factors that play a fundamental role in the etiology of the disease. The current and emerging drug targets are also discussed.